70.0 Million

Over 70 million women and men in the USA are at risk of Alzheimer’s disease and cognitive decline.

Today, there are no drugs that modify the course of Alzheimer’s disease. However, extensive research (such as the FINGER study and its worldwide follow-ons, and work at Weill Cornell) demonstrates value in early intervention and prevention for those at risk of Alzheimer’s disease. The biological progression of Alzheimer’s disease tends to start in the brain 10 to 20 years before the onset of symptoms. Thus, there is an opportunity to address its risk factors aggressively at younger ages – people in their 40s and 50s – long before symptoms can emerge.


The ExtND METHOD enables doctors to have a straightforward way to practice and prevent brain decline, by providing personalized plans tailored to each individual.


We value your privacy. Your personal information is kept confidential and not sold to third parties. It is only used for communications you request related to the services provided by uMETHOD.